Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

Presta, 1993, Humanization of an antibody directed against IgE, J Immunol, 151, 2623, 10.4049/jimmunol.151.5.2623

Boulet, 1997, Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response, Am J Respir Crit Care Med, 155, 1835, 10.1164/ajrccm.155.6.9196083

Corne, 1997, The effect of intravenous administration of a chimeric anti-IgE antibody on serum IgE levels in atopic subjects: efficacy, safety, and pharmacokinetics, J Clin Invest, 99, 879, 10.1172/JCI119252

Fahy, 1997, The effect of an anti-IgE monoclonal antibody on the early- and late- phase responses to allergen inhalation in asthmatic subjects, Am J Respir Crit Care Med, 155, 1828, 10.1164/ajrccm.155.6.9196082

Casale, 1997, Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis, JAllergy Clin Immunol, 100, 110, 10.1016/S0091-6749(97)70202-1

MacGlashan, 1997, Down-regulation of FceRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody, J Immunol, 158, 1438, 10.4049/jimmunol.158.3.1438

National Asthma Education and Prevention Program, 1997

Hoskins, 2000, Risk factors and costs associated with an asthma attack, Thorax, 55, 19, 10.1136/thorax.55.1.19

Milgrom, 1999, Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group, N Engl J Med, 341, 1966, 10.1056/NEJM199912233412603

Fox, 1997, Pharmacokinetics and clearance mechanisms of anti-IgE: IgE monoclonal and polyclonal complexes [abstract no. 2015], Pharm Res, 14, S217

Shields, 1995, Inhibition of allergic reactions with antibodies to IgE, Int Arch Allergy Immunol, 107, 308, 10.1159/000237010

Coyle, 1996, Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a nonanaphylactogenic anti-IgE antibody, J Exp Med, 183, 1303, 10.1084/jem.183.4.1303

Silkoff, 2000, Exhaled nitric oxide (ENO) and anti-inflammatory effects of a recombinant humanized monoclonal antibody to IgE (rhuMAb-E25) in pediatric asthma, Chest, 118, 101S

Lemanske, 1997, Asthma, JAMA, 278, 1855, 10.1001/jama.1997.03550220061010

Martinez, 1995, Asthma and wheezing in the first six years of life. The Group Health Medical Associates, N Engl J Med, 332, 133, 10.1056/NEJM199501193320301

Adelroth, 2000, Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis, J Allergy Clin Immunol, 106, 253, 10.1067/mai.2000.108310